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Total mesorectal excision (TME) has gained worldwide acceptance as a standard surgical technique in the treatment of 
rectal cancer. Ever since laparoscopic surgery was first applied to TME for rectal cancer, with increasing penetration rates, 
especially in Asia, an unstable camera platform, the limited mobility of straight laparoscopic instruments, the two-dimen-
sional imaging, and a poor ergonomic position for surgeons have been regarded as limitations. Robotic technology was 
developed in an attempt to reduce the limitations of laparoscopic surgery. The robotic system has many advantages, in-
cluding a more ergonomic position, stable camera platform and stereoscopic view, as well as elimination of tremor and 
subsequent improved dexterity. Current comparison data between robotic and laparoscopic rectal cancer surgery show 
similar intraoperative results and morbidity, postoperative recovery, and short-term oncologic outcomes. Potential bene-
fits of a robotic system include reduction of surgeon’s fatigue during surgery, improved performance and safety for intra-
corporeal suture, reduction of postoperative complications, sharper and more meticulous dissection, and completion of 
autonomic nerve preservation techniques. However, the higher cost for a robotic system still remains an obstacle to wide 
application, and many socioeconomic issues remain to be solved in the future. In addition, we need more concrete evi-
dence regarding the merits for both patients and surgeons, as well as the merits compared to conventional laparoscopic 
techniques. Therefore, we need large-scale prospective randomized clinical trials to prove the potential benefits of robot 
TME for the treatment of rectal cancer.
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subsequently resulting in not only en-bloc removal of rectal 
cancer and surrounding mesorectum containing a lymph node, 
but also pelvic autonomic nerve preservation [2]. The quality of 
the macroscopic specimen for rectal cancer has been regarded 
as an important parameter for prediction of prognosis [3, 4]. 
Oncologically, there must be no damage to the mesorectum 
during dissection, and a clear circumferential resection margin 
and distal resection margin should be obtained after resection.
With the development of new technologies, laparoscopic sur-
gery has been applied to colorectal cancer resection [5]. Ini-
tially, there were many concerns regarding oncologic safety, 
even though it was associated with better short-term clinical 
outcomes, such as earlier recovery of bowel function, less pain, 
cosmetic advantages, shorter hospital stay, etc. [6]. Therefore, a 
couple of prospective randomized clinical trials were conducted 
to compare the operative and oncologic safety between open 
and laparoscopic surgery for the treatment of colorectal cancer 
[7-10]. As a result, in comparison with open surgery, oncologic 
safety was confirmed for colon resection by laparoscopy [8]. 
However, for rectal cancer, the issue of oncologic safety has not 
INTRODUCTION
Total mesorectal excision (TME), introduced by Heald et al. 
[1] in 1982 has revolutionized the surgical management of rec-
tal cancer. TME has gained worldwide acceptance as a standard 
surgical technique. Actually, its use can result in a dramatic re-
duction of the local recurrence rate [2]. Its principles have been 
advocated for sharp pelvic dissection based on pelvic anatomy, 
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yet been adequately resolved. Rather, there are still some con-
cerns regarding laparoroscopic rectal surgery due to the high 
conversion rate or the high proportion of circumferential re-
section margin positive rates in the Medical Research Council 
Conventional versus Laparoscopic-assisted Surgery in Colorec-
tal Cancer (MRC_CLASICC) trial [10]. These disappointing 
early results may originate from many factors. The inherent 
limitations of laparoscopic rectal resection, such as an unstable 
camera platform, limited mobility of straight laparoscopic in-
struments, two-dimensional imaging, and a poor ergonomic 
position for surgeons may be some of those factors. 
Robotic technology was developed in an attempt to reduce 
the limitations of laparoscopy [11, 12]. The current system, the 
da VinciTM robot (Intuitive Surgical Inc., Sunnyvale, CA, USA), 
overcomes many of the inherent constraints of laparoscopy, 
such as the fulcrum effect, poor depth perception, decreased 
range of motion, and instrument tremor. In addition, robotic 
technology allows motion scaling, surgeon-controlled three-
dimensional camera navigation, and remote telesurgical appli-
cations [11]. The robotic system was adapted to rectal cancer 
surgery with the expectation that secure dissection of an avas-
cular plane between the presacral fascia and the fascia propria 
of the rectum without injury to the integrity of the mesorectum 
in the narrow pelvic cavity could be more easily performed by 
using precise robotic arms and a stable stereoscopic magnified 
view with high illumination.
However, with respect to the treatment of rectal cancer, what 
is the best method for both patients and surgeons? The extent 
and the quality of a surgical resection must be identical, regard-
less of any modalities. Even though laparoscopy or robotic sur-
gical techniques have shown better short-term clinical outcomes, 
fundamental concepts and the extent of surgical techniques 
should not differ from those of open surgery, meaning that any 
modalities must keep the principles of TME. Therefore, some 
concerns regarding oncologic safety in minimally invasive rec-
tal cancer surgery still remain.
A multimodality team approach (MTA) according to the pa-
tient’s initial stage has recently been considered as an essential 
tool for improving the oncologic outcome and the quality of 
life of a patient with rectal cancer. MTA means that treatment 
methods should be discussed and decided by cooperation of 
various departments, including surgery, radiation oncology, 
medical oncology, gastroenterology, diagnostic radiology, etc. 
A proper surgical approach should also be discussed and decided 
using MTA. Even if surgeons may choose minimally invasive 
surgery (laparoscopy or robot), the most important consider-
ation is that they should follow the same principles of standard 
surgical techniques and perform the standard extent of surgery, 
which are essential for a patient’s cure. In this review, we attempt 
to investigate the current status and potential benefits of mini-
mally invasive surgery, compared with open surgery, in the 
treatment of rectal cancer, with consideration for multidimen-
sional aspects.
PENETRATION RATE OF LAPAROSCOPIC 
TME
Data retrieved from the Health Insurance Review and Assess-
ment (HIRA, Korea) service by the Korean Study Group of Lap-
aroscopic Colorectal Cancer Surgery shows that the annual num-
ber of surgical procedures for the treatment of colorectal can-
cer in Korea increased year by year and reached 13,683 cases 
in 2008. Among them, there were 4,762 cases of rectal cancer 
(Fig. 1).
The penetration rate of laparoscopic surgery for the treatment 
of colon cancer was 27.8% (3,144/11,325) in 2006, which in-
creased to 49.1% (6,715/13,682) in 2008. The penetration rate 
of laparoscopic surgery for the treatment of rectal cancer was 
24.5% (1,098/4,478) in 2006, which also increased to 48.1% 
(2,290/4,763) in 2008 (Fig. 2). As far as we know, this penetra-
tion rate was as high as that of Japan. Compared to the relatively 
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Fig. 1. Penetration rate of laparoscopic surgery for total colorectal 
cancer in Korea (Courtesy of Prof. K. Y. Lee, M.D., Kyung Hee Uni-
versity School of Medicine, Seoul, Korea).
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Fig. 2. Penetration rate of laparoscopic surgery for rectal cancer in 
Korea (Courtesy of Prof. K. Y. Lee, M.D., Kyung Hee University School 
of Medicine, Seoul, Korea).
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higher penetration rates in Korea, the average penetration rate 
of laparoscopic surgery in cases of colorectal cancer was esti-
mated at below 20% in the USA and Europe [13, 14].
The low penetration rate in the USA may have originated from 
the high prevalence rate of obese patients, which causes greater 
difficulty and is more time-consuming than open surgery for 
adequate surgical dissection, such as TME, for the treatment 
of rectal cancer. Rea et al. [14] reported interesting data at the 
2010 American Society of Colon and Rectal Surgeons (ASCRS) 
meeting (Minneapolis, MN, USA). They analyzed data regard-
ing utilization of a laparoscopic colectomy in the USA before 
and after the Clinical Outcomes of Surgical Therapy (COST) 
Study Group Trial. Elective laparoscopic surgery for treatment 
of benign disease increased from 5.3% in 2002-2003 to 8.3% in 
2005-2006 while the laparoscopic colectomy for the treatment 
of cancer increased by a larger percentage over the same time 
frame, 2.6% to 7.9%. They concluded that within two years af-
ter publication of the COST trial, the use of a laparoscopic re-
section for the treatment of colon cancer almost equalled that of 
benign disease. However, over 90% of cases are still performed 
with an open approach, and this treatment option is influenced 
by socioeconomic factors, including gender, race, income, health 
insurance status, and hospital type.
COMPARISON OF TECHNICAL ASPECTS 
BETWEEN LAPAROSCOPY AND A ROBOTIC 
SYSTEM AND CURRENT EVOLUTION IN THE 
TREATMENT OF RECTAL CANCER BY USING 
A ROBOTIC SYSTEM
Laparoscopic rectal cancer surgery has some limitations, in-
cluding a 2-dimensional view, demands for a skilled assistant 
for a stable camera and proper retraction of the bowel, and lim-
ited dexterity of the laparoscopic instruments owing to a nar-
row pelvic cavity. These various factors result in a steep techni-
cal learning curve for laparoscopic TME, which is not easy to 
overcome [15, 16].
The robotic system has many advantages, including a more 
ergonomic position, stable camera platform and stereoscopic 
view, as well as elimination of tremor and subsequent improved 
dexterity. Due to these advantages of the robotic system, it has 
been applied to various complex surgeries, including prostatec-
tomies, esophagectomies, gastrectomies, thyroidectomy, pan-
creaticoduodenectomies, hepatectomies etc. [11]. Thus far, a 
couple of sets of data have been published in many fields of 
cancer surgery. Likewise, robot-assisted TME affords the sur-
geon an improved 3-dimensional vision, ergonomics of the 
operating console, tremor elimination, superior dexterity, and 
relief of surgeons’ discomfort, which could result in attenuation 
of the necessary learning curve for minimally invasive meso-
rectal excision. 
So far, two different modalities of robotic rectal cancer sur-
gery have been applied in clinical practice. One is the hybrid 
method, and the other is the totally robotic surgery. In brief, 
the hybrid method is composed of a laparoscopic procedure 
(mobilization of the sigmoid and the left colon, ligation of the 
inferior mesenteric artery and vein) and a robotic procedure 
(pelvic dissection). A totally robotic method means that all 
procedures are performed with a robotic system. Each proce-
dure has its own merits and demerits. We need more data to 
compare the efficacies of the various methods. 
One of the most outstanding features is that the so-called 
‘Natural Orifice Specimen Extraction (NOSE)’ technique can 
be performed more easily by using a robot. In the NOSE pro-
cedure, specimen retrieval is carried out using a natural orifice 
(e.g., anus or vagina) instead of a minilaparotomy. Choi et al. 
[17] reported their initial experience of transanal or transvagi-
nal retrieval of the specimen in robotic-assisted anterior resec-
tion. They concluded that robotic-assisted laparoscopic meth-
ods were safe and feasible modalities to avoid the traditional 
abdominal incision. Following these results, they showed that 
the NOSE procedure could be more easily performed using a 
robotic system than a conventional laparoscopic technique and 
that it could reduce the postoperative pain score compared to 
a conventional minilaparotomy [18]. 
Another advancement is education derived from the progress 
of technology. As the da Vinci system has been developed, we 
can now use two console boxes. Because of this system, less-
experienced surgeons are more apt to be trained for robotic 
technique with supervision by a more-experienced surgeon. 
Although there are many potential advantages in the robotic 
system for rectal cancer surgery, unfortunately, in terms of both 
surgeons and patients, there has been a lack of concrete evidence 
of the benefits.
LAPAROSCOPIC VS. ROBOTIC TME: 
CURRENT STATUS BASED ON THE 
LITERATURE
Since the introduction of the robotic system for use in rectal 
cancer surgery, the safety and feasibility have been confirmed 
by several studies [19-22]. A few comparative results for lapa-
roscopic versus robotic TME have recently been published [23-
26]. Except for one randomized design, most of those were non-
randomized comparative studies. With the current evidence, 
we can investigate early postoperative morbidity and oncologic 
aspects regarding specimen quality. 
Intraoperative results 
Conversion rates ranged from 0 to 22% for a laparoscopic TME 
(LTME) and from 0 to 7.3% for a robotic TME (RTME). In one 
randomized study by Baik et al. [25], the conversion rate for a 
RTME was found to be statistically lower than that for a LTME 
(0% vs. 10.5%, P = 0.013). However, in other studies, no difference 
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in conversion rate was observed between the two modalities.
With the exception of one study, the operative time showed 
no difference. Park et al. [24] reported longer operative times 
in the robotic group than in the laparoscopic group (231.9 min-
utes vs. 168.6 minutes, P < 0.001). This result could be explained 
by the surgeon’s previous abundant experience of more than 400 
cases of laparoscopic resection before starting robotic rectal re-
section, as reported in the study by Park et al. [24] There were 
no differences for parameters reflecting difficulties of dissec-
tion, such as median estimated blood loss, hemoglobin change 
during surgery or need for intraoperative transfusion between 
LTME and RTME.
Postoperative morbidity and recovery
No difference in the postoperative complication rate was ob-
served between LTME and RTME, ranging from 19.3% to 26.8 
% in LTME and from 10.7% to 29.3% in RTME. The most seri-
ous complication after rectal resection is anastomotic leakage. 
The anastomotic leakage rate ranged from 1.7% to 9.7% for 
RTME. In contrast, it ranged from 2.4% to 7.5% for LTME. No 
difference was observed between the two modalities. However, 
Baik et al. [25] reported a low rate of serious complications, 
including anastomotic leakage, in RTME (5.4% vs. 19.3%, P = 
0.025). In their study, there was only one anastomotic leakage 
for RTME and four anastomotic leakages for LTME. 
Bianchi et al. [26] reported one reoperation due to peritonitis 
in post operative day after RTME. This complication originated 
from a small bowel perforation. Even though it is rare, surgeons 
who start robotic surgery should be aware of this kind of com-
plication originating from unfamiliar handling of the robotic 
arm. 
Baik et al. [25] reported on the earlier start of a soft diet and 
a shorter hospital stay with RTME. However, other studies have 
reported no difference for the first bowel movement, start of 
diet, and length of hospital stay. 
Short-term oncologic outcomes
Use of robotic surgery for the treatment of rectal cancer has 
been relatively recent; therefore, data regarding long-term on-
cologic outcome are very limited. Baek et al. [27] recently re-
ported their oncologic outcome as a 96.2% 3-year overall sur-
vival and a 73.7% 3-year disease-free survival with a mean fol-
low up of 20.2 months. However, in cases of comparison stud-
ies between LTME and RTME, no result on long-term onco-
logic outcomes has been reported. Instead, most studies have 
compared the distal resection margin, the circumferential re-
section margin’s involvement status, and the numbers of total 
harvested lymph nodes as early oncologic parameters. No dif-
ference in circumferential resection margin involvement rates 
has been reported. The median distal resection margin ranged 
from 2.1 cm to 4.0 cm in RTME and from 2.3 cm to 3.8 cm in 
LTME. The median numbers of harvested lymph nodes were 
13.1 to 18.4 for RTME and 14.2 to 18.7 for LTME. No difference 
was found with respect to distal resection margin and numbers 
of harvested lymph node numbers. Of particular interest, Baik 
et al. [27] compared the quality of the mesorectum after com-
pletion of surgery. Macroscopic judgements of the specimen 
were classified as complete, nearly complete, and incomplete. 
Superiority of mesorectal integrity in RTME compared to LTME 
was observed in that study (P = 0.033). However, with respect to 
early oncologic outcomes, no difference was observed between 
laparoscopic versus robotic TME, showing oncologic safety for 
both RTME and LTME. These results suggest that according to 
the current evidence, there is no difference for postoperative 
recovery, morbidity, and early oncologic outcomes between 
RTME and LTME. With respect to conversion rate and opera-
tive time, even though in some studies, RTME showed better 
outcomes, more data are required in order to draw a definite 
conclusion.
Another point is that, the competence of the surgeon in either 
modality may affect the surgical outcome. No difference in out-
comes was observed between LTME and RTME when LTME 
was performed by an experienced laparoscopic surgeon. In some 
points of view, this may be a reflection of the short learning 
curve of RTME. Therefore, to clarify the real benefits of RTME, 
surgeon factors should also be considered in future studies. 
POTENTIAL BENEFITS OF ROBOTS
Self-controllable camera function 
In the performance of laparoscopic surgery, an assistant should 
control the laparoscopic image by directing the laparoscopic 
camera on the operative field, following the instructions of the 
surgeon. This task requires ongoing active communication be-
tween the surgeon and the assistant in the same operation the-
ater. Therefore, physical space conflicts or inevitable confusion 
between the surgeon and the assistant may arise during sur-
gery. Besides, human camera control may result in a subopti-
mal image due to tremor, off-center drift, or loss of horizontal 
orientation; therefore, frequent correction is required during 
surgery. In addition, inadvertent collisions with tissue may re-
sult in the need to clean the lens frequently. These problems 
tend to diminish the concentration of the surgeon and impede 
the flow of the operation. However, the robotic system has a 
self-controllable camera platform, which is very stable and pro-
vides a stereoscopic view. For this reason, much attention is now 
being paid to the robotic surgery. 
Surgeon’s fatigue
Van Koughnett et al. [28] developed a subjective scale for as-
sessing robotic surgery. Twenty choledochojejunostomies were 
performed in an ex-vivo pig model. Ten anastomoses were per-
formed laparoscopically, and ten anastomoses by using da Vinci 
robot assistance. They completed the scale form after each pro-
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cedure. Robotic surgery was associated with superior ease, com-
pared to laparoscopy, in 8 of the 13 factors, including image 
quality, depth perception, comfort, eye fatigue, dexterity, pre-
cision of motion, speed of motion, and range of motion.
One possible advantage of robotic-assisted surgery is that sur-
geons may feel more comfortable using robotic assistance over 
conventional laparoscopy, which might originate from surgeon’s 
sitting at a console during surgery, the fine EndowristTM (Intui-
tive Surgical, Sunnyvale, CA, USA) movement of the da Vinci 
system, etc. However, little evidence is available to substantiate 
this potential benefit. Future research must be planned in order 
to validate the subjective assessment scale for the evaluation of 
surgeon’s fatigue. 
Improved performance and safety for intracorporeal suture
Robotic technology was developed in an attempt to reduce 
many of the limitations of laparoscopy while maintaining its 
minimally invasive nature. Stefanidis et al. [29] reported the 
intracorporeal suture to be one of the most difficult laparoscopic 
tasks. They assessed the impact of robotic assistance on the su-
turing performance of a novice and on the safety and the work-
load in the operating room. Results revealed that robotic assis-
tance resulted in significantly improved intracorporeal sutur-
ing performance and safety while decreasing workload in the 
operating room. Robotic suturing showed a better learning 
curve comparison score than laparoscopic suturing (P < 0.001). 
Besides, participants’ workload was significantly lower with 
robotic suturing than with laparoscopic suturing (P < 0.001). 
In conclusion, robotic assistance could lead to improved nov-
ice suturing performance, limit the number of inadvertent in-
juries to structures outside the operating field and decrease 
operator workload in a live animal model. 
Postoperative complications: Can robots reduce the 
morbidity?
Concerns have been raised with regard to the high rate of anas-
tomotic leakage after a laparoscopic low anterior resection for 
the treatment of rectal cancer. Many relevant clinical factors 
related to anastomotic leakage have been reported [30-35]. One 
of the most important issues regarding anastomotic leakage in 
laparoscopic surgery is known as the stapled rectal resection 
[31, 32]. Perpendicular application of endostaples to the pro-
posed resection line of the rectum is very difficult; therefore, 
the number of endostaples may be increased for complete tran-
section of the rectum, which might be related to anastomotic 
leakage when anastomosis is performed using the double sta-
pled method. Kim et al. [32] reported that the number of lin-
ear endostapler firings was significantly related to anastomotic 
leakage in men. The robotic system might help to reduce the 
number of endostapler firings, or anastomosis with one stapler 
may be more easily performed [17]. Following retraction of 
the specimen through the anal canal, a purse-string suture can 
be applied to the proximal end of the colon, and anastomosis 
can be safely performed by using a single circular stapler, which 
can subsequently be expected to reduce the rate of anastomo-
sis leakage. In addition, a reinforcement suture can be easily 
applied to the corner of the anastomosis after a double stapling 
technique using the Endowrist function, which would be very 
difficult when using a laparoscopic camera system and lapa-
roscpic instruments. Based on these concepts, we believe that 
the robotic system can reduce the problem of anastomotic leak-
age in a low anterior resection.
Sharper and more anatomical pelvic dissection: How is it 
possible?
Sharper and more meticulous dissection
TME has been emphasized by Dr. Heald and advocated by many 
colorectal surgeons. Originally, he emphasized that the rectum 
and the mesorectum should be removed as an intact unit with 
meticulous sharp pelvic dissection under direct vision, staying 
between the visceral and the parietal pelvic fascia down to the 
level of the levator muscle [1, 2]. Sharp dissection under direct 
vision with good illumination is essential during the period of 
open TME. In addition, gentle opening of the plane by contin-
uous traction and counter-traction is essential. With robotic 
pelvic dissection, an excellent stereoscopic view can be obtained 
with high illumination. In addition, with the robotic system, 
traction and counter-traction can be easily realized in a narrow 
pelvic space by using Endowrist. One of the advantages is that 
the 3rd robotic arm can be used. Steady counter-traction is uti-
lized for exposure of the operative field, and a sharp pelvic dis-
section may be performed. More precise dissection on the “holy 
plane” between the presacral fascia and the fascia propria of the 
rectum can be expected with the robotic system, resulting in 
higher quality of the TME specimen. In particular, during an-
terior dissection of the seminal vesicle or vagina from Denon-
villiers’ fascia, which is regarded as an important part of dissec-
tion, the robotic system will be helpful in finding and keeping 
the correct anatomical plane due to the stability of the camera 
platform and consistent, steady counter-traction by the 3rd ro-
botic arm. As far as autonomic nerve preservation is concerned, 
the more magnified view, compared to laparoscopy or the na-
ked eye, provides the ability to identify nerve structures.
Personally, dissection of the lower part of the rectum using 
robotic techniques will be helpful in gaining access to the oper-
ative field in any direction when using the self-controlled cam-
era system, allowing clearer visibility for determining the rela-
tionship of the lower rectum to the levator ani muscle. Neuro-
vascular bundles are also clearly visible from the pelvic plexus 
and are easily separated from the rectum. Sometimes, we can 
locate the middle rectal artery and then dissect the middle rec-
tal artery and divide it with clipping.
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Lateral ligament in rectal cancer surgery by robotic view 
A couple of important issues regarding the anatomy of the 
rectum and the surrounding structures have been under debate. 
The presence of the lateral ligament has been actively discussed 
as a topic of pelvic dissection due to the fact that definition and 
proper division of the lateral ligaments is an essential step in 
achieving full mobilization of the rectum. In addition, gentle 
handling of lateral ligaments has been associated with preser-
vation of sexual and urinary function. During the open TME 
era, posterior and anterior rectal mobilization was always per-
formed according to anatomical landmarks. The main limiting 
factor for preventing delivery of the rectum from the pelvic in-
let has been the lateral part of the rectum. The presence of lat-
eral ligaments has been debated in previous anatomical studies 
[36-39]. Pak-art et al. [37] beautifully demonstrated an actual 
lateral ligament by using a cadaveric hemipelvis dissection and 
concluded that the lateral ligament was present and that it con-
sisted of loose connective tissue with clusters of small nerves. 
However, according to other observers, the actual position of 
the lateral ligament was different. Kinugasa et al. [39] insisted 
that it was located between the mesorectum and the pelvic wall 
at the ventrolateral side of the pelvic splanchnic nerves; how-
ever, Pak-art et al. [37] observed that it was located at the me-
dial side of the pelvic splanchnic nerves originating from the 
anterior foramina of S3 and S4. Based on our perspectives, def-
inite ligamentous structures between the rectal wall and the 
pelvic wall are present, and these structures are usually located 
at an adjacent structure, such as the pelvic plexus or the mid-
dle rectal artery. Therefore, traction and division of the lateral 
part of the rectum has been emphasized for precise dissection 
to avoid injury to the pelvic plexus and the middle rectal artery. 
In the robotic era, with a stereoscopic view and self-controlled 
camera platform, these areas appear to be more clearly visible. 
The ligament appears to be only an adhesion between the pel-
vic plexus and the mesorectal fascia of the rectum. Careful and 
precise dissection should be performed in this area, and the rec-
tum should be mobilized carefully and separated from the pel-
vic plexus. If the middle rectal artery is detected during surgery, 
careful ligation or cauterization under robotic assistance is not 
difficult. The question of whether or not the lateral ligament is 
present is no longer discussed because the interesting points of 
the past are no longer a secret. 
Autonomic nerve preservation techniques
The sympathetic paraaortic nerve plexux and the superior hy-
pogastric nerve plexus have usually been found around the or-
igin of the inferior mesenteric artery. Injury to these nerves re-
sults in sexual dysfunction, such as retrograde ejaculation [40]. 
Under robotic view, we were able to obtain some benefits with 
regard to differentiation of nerves and lymphatics from other 
structures because these nerve structures may be more clearly 
visible. Practical important points for preservation of the pel-
vic plexus and neurovascular bundles lie in two steps. The first 
step is careful separation of the lateral rectal wall with proper 
traction from the pelvic plexus (coarse and flat meshwork), 
which consists of the parasympathetic nerve from the sacral 
foramen. The second step is a precise incision on the Denon-
villers’ fascia at the seminal vesicle. Dissection behind the plane 
of the Denonvilliers’ fascia is more helpful for preservation of 
the neurovascular bundles from the genital organs because these 
neurovascular bundles usually run along the lateral corner of 
the seminal vesicle and Denonvilliers’ fascia will continue to 
the pelvic plexus. Dr. Kinugasa’s studies using cadavers have 
shown the important relationship between Denonvilliers’ fas-
cia and neurovascular bundles [39].
Denonvilliers’ fascia was defined as a thick connective tissue 
layer extending along the long course behind the prostate cap-
sule, in addition to the seminal vesicle. This fascia ended at the 
plexus area, and one of the lateral continuations of Denonvil-
liers’ fascia extended dorsolaterally and separated the meso-
rectum from the urogenital neurovascular bundle. It primarily 
invaded the superior part of the pelvic plexus at the lateral edge 
of the TME plane. Therefore, the dissection plane should be 
kept along the plane behind the Denonvilliers’ fascia. In addi-
tion, Wallner et al. [41], based on cadaveric dissection and clin-
ical case analysis, insisted that fecal and urinary incontinence 
after a TME was possible due to levator ani nerve disruption. 
They observed that the levator ani nerve could be disrupted 
during pelvic dissection of the lower part at the pelvic floor, 
especially during separation of the mesorectal fascia from the 
parietal fascia. Therefore, an appropriate surgical plane should 
be more medial to the parietal pelvic fascia covering the leva-
tor ani nerve and the levator ani muscle between the posterior 
wall of the rectum and the sacrum. Those delicate neurovascu-
lar structures are more visible when using a robotic 3-dimen-
sional stereoscopic viewing system.
INITIAL PERSONAL EXPERIENCES
Robotic rectal cancer surgery compared with laparoscopy 
and open surgery (100 cases per group)
We have investigated short term clinical outcomes and patho-
logic results between open, laparoscopic, and robotic surgery 
for the treatment of rectal cancer. About 100 patients in each 
group were enrolled from January 2008 to December 2009. 
The proportion of patients with distal rectal cancer and the 
number of patients who received preoperative chemoradiation 
therapy was higher in the open surgery group than in the lapa-
roscopy or robotic group. Age and sex distribution did not dif-
fer between the groups, and BMI and other factors were same 
(Table 1).
The conversion rate was 2% in the robotic group and 3% in the 
laparoscopy group. The mean operative time was longer in the 
robotic group than in the open and laparoscopy groups. The 
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circumferential resection margin’s positive rate and the mean 
of distal resection margin did not differ between the groups. 
However, the total number of retrieved lymph nodes was larger 
in the open group than in the laparoscopy or the robotic group 
(Table 2). The robotic group showed better short-term clinical 
outcomes than the laparoscopy or the open group in respect to 
the first flatus, soft diet intake, and hospital stay (Table 3).
Surgical site infection and pulmonary complications were 
more common in the open group than in the laparoscopy or 
the robotic group. The rate of anastomotic leakage was 8.2% in 
Table 1. Clinicopathological characteristics of enrolled patients
Robot	(n	=	100)	 Laparoscopy	(n	=	100)	 Open	(n	=	100)	 P-value	
Male 70 (70.0) 57 (57.0) 64 (64.0) 0.16
Age (yr)   57.9 ± 11.3   61.4 ± 10.8   58.9 ± 11.2 0.076
BMI (kg/m2) 23.6 ± 2.6 23.5 ± 3.1 23.1 ± 2.5 0.405
Comorbidity
   Cardiovascular 
   Endocrine 
25 (25.0) 
13 (13.0) 
23 (23.0) 
21 (21.0) 
20 (20.0) 
26 (26.0) 
0.399
0.022
PAS 7 (7.0) 10 (10.0) 8 (8.0) 0.798
ASA grade 
   1
   2
   3
65 (65.0)
33 (33.0) 
2 (2.0) 
51 (51.0)
44 (44.0) 
5 (5.0) 
70 (70.0)
28 (28.0) 
2 (2.0) 
0.521
Tumor location (cm)
   Low (≤ 6) 
   Mid (6-12) 
   Upper (12-15) 
32 (32.0) 
49 (49.0) 
19 (19.0) 
19 (19.0) 
64 (64.0) 
17 (17.0) 
46 (46.0) 
45 (45.0) 
9 (9.0) 
0.011
CEA (ng/mL) 
   ≤ 5
   > 5 
85 (85.0)
17 (15.0) 
82 (82.0)
18 (18.0) 
71 (71.0)
29 (29.0) 
0.015
LVI 16 (16.0) 22 (22.0) 26 (26.0) 0.085
Preoperative CRT 14 (14.0) 7 (7.0) 46 (46.0) <0.001 
Values are presented as mean ± SD or number (%). 
BMI, body mass index; PAS, past abdominal surgery; ASA, American Society of Anesthesiology; CEA, carcinoembryonic antigen; LVI, lymphovascular invasion; CRT, 
chemoradiation.
Table 2. Perioperative surgical outcomes
Robot	(n	=	100)	 Laparoscopy	(n	=	100)	 Open	(n	=	100)	 	P-value	
Sphincter preserving surgery 98 (98.0) 99 (99.0) 75 (75.0) <0.001 
Open conversion 2 (2.0) 3 (3.0) - 1.0* 
Mean operative time (min)   385.3 ± 102.6  297.3 ± 83.7 282.7 ± 102.2 0.001
Diverting loop ileostomy 30 (30.0) 27 (27.0) 28 (28.0) 0.754
Transfusion 4 (4.0) 6 (6.0) 11 (11.0) 0.053
Tumor diameter (cm)   3.6 ± 2.0    3.3 ± 2.0   3.5 ± 2.1 0.605
Distal resection margin (cm)   2.7 ± 1.9    2.6 ± 1.8   3.2 ± 2.9 0.092
Circumferential resection margin involved 3 (3.0) 2 (2.0) 3 (3.0) 1
Retrieved lymph node (n) 14.7 ± 9.7  16.6 ± 9.1 21.0 ± 14.2 <0.001 
Pathologic stage 
   pCR, Stage I 
   Stage II 
   Stage III 
32 (32.0) 
30 (30.0) 
38 (38.0) 
37 (37.0) 
25 (25.0) 
38 (38.0) 
27 (27.0) 
27 (27.0) 
46 (46.0) 
0.279
Values are presented as mean ± SD or number (%). 
pCR, pathologic complete remission.
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the robotic group, 11.1% in the laparoscopy group, and 2.7% 
in the open group, but these differences were not statistically 
significant (P = 0.227) (Table 4).
Voiding and sexual function between laparoscopy and 
robot rectal TME
Our hypothesis is that meticulous, precise dissection with steady 
counter traction by a robotic arm could make visualizing and 
preserving the pelvic autonomic nerves better. Patients enrolled 
in the study included 39 patients in the laparoscopy group and 
30 patients in the robotic group. We investigated patients us-
ing a questionnaire to assess voiding and sexual function be-
fore and after TME at 1, 3, 6, and 12 months after surgery. The 
IPSS score had decreased to normal at 3 months after TME in 
the robotic group, and voiding volume appeared to be normal 
at 1 month after TME in the robotic group. Erectile function 
was measured as IIEF at 1, 3, 6, and 12 months after TME, and 
showed a return to normal level at 6 month in the robotic sur-
gery group. Based on our experiences, overall voiding and void-
ing function will be recovered and come back safely and more 
rapidly with robotic surgery than with laparoscopy. 
LIMITATIONS OF CURRENT ROBOT SYSTEM
Is there any cost-effectiveness for robots? 
The main limitation of propagation of robotic TME in the treat-
ment of rectal cancer in Korea is the high cost. We analyzed 
and compared total payments and total burdens by patients 
between robotic, laparoscopy, and open surgery for the treat-
ment of rectal cancer. We analyzed a total of 30 patients (10 
patients in each group) who underwent surgery at our hospi-
tal. They recovered and were discharged on time without any 
complications.
The means of total hospital costs were 14,080 USD in robotic 
surgery, 9,120 USD in laparoscopy surgery and 8,386 USD in 
open surgery (P < 0.01). Total cost burdens by patients were 
11,886 USD in robotic surgery, 3,989 USD in laparoscopy sur-
gery and 3,472 USD in open surgery (P < 0.01) (Fig. 3). In Korea, 
the cost of robotic surgery is not reimbursed by the national 
insurance system. Therefore, the cost of using robotic systems 
and related supplies must be paid by the patients themselves.
Of particular interest, Rawlings et al. [42] analyzed costs be-
tween the laparoscopy and the robotic groups. In right hemi-
colectomies, total hospital costs showed no statistically signifi-
cant difference between laparoscopy and robotic surgery (P = 
0.43), even though costs for operating-room time and operat-
ing-room supplies were higher in the robotic group than in 
the laparoscopy group. With respect to sigmoid colectomies, 
total hospital costs showed no differences between the laparos-
copy group and the robotic group (P = 0.735). Although there 
was no difference in operating-room time cost between the two 
groups, the operating-room supply costs were higher in the ro-
botic group than in the laparoscopy group.
Technical limitations
The robotic system currently in use still has technical limita-
Table 3. Postoperative recovery between the three groups
	Robot	
(n	=	100)	
	Laparoscopy	
(n	=	100)	
	Open	
(n	=	100)	
	P-value
First flatus (day)   2.6 ± 0.9 3.0 ± 1.2   3.7 ± 1.3 <0.001 
Soft diet intake (day)   5.8 ± 3.8 7.4 ± 5.4   6.2 ± 1.7 0.016
Hospital stay (day) 11.7 ± 6.7 14.4 ± 10.0 15.4 ± 7.9 0.006
Table 4. Operation-related morbidity between the three groups
	Robot	
(n	=	100)	
	Laparoscopy	
(n	=	100)	
	Open	
(n	=	100)	
P-value	
Complications 
Overall     20 (20.0)    27 (27.0)    25 (25.0) 0.409
Anastomotic leakagea    8 (8.2)    11 (11.1)    2 (2.7) 0.227
Pelvic abscess    2 (2.0)    2 (2.0)    3 (3.0) 0.64
Voiding difficulty    4 (4.0)    9 (9.0)    5 (5.0) 0.766
Ileus/obstruction    3 (3.0)    2 (2.0)    5 (5.0) 0.432
Wound infection    1 (1.0)    1 (1.0)    6 (6.0) 0.028
Respiratory problem 0 (0) 0 (0)    3 (3.0) 0.033
Bleeding    1 (1.0) 0 (0) 0 (0) 0.221
Acute renal failure 0 (0) 0 (0)    1 (1.0) 0.221
Adjacent organ injury 
during surgery 
   1 (1.0)    2 (2.0) 0 (0) 0.478
Values are presented as number (%). 
aPatients who underwent abdominoperineal resection were excluded in this ana-
lysis.
	 Robot	 Laparoscopy	 Open
Total	payment Total	burden	by	patients
Fig. 3. Comparison of total cost under Korea medical insurance sys-
tem: robot vs. laparoscopy vs. open surgery for rectal cancer.
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tions [43]. First, with respect to visual systems, 3-dimensional 
vision is only appreciated by the operating surgeon, not by the 
surgical assistant. Though surgeons can magnify the target or-
gan by using the camera system, it is difficult to zoom-out for 
an overview during surgery, which is sometimes essential for 
multi-quadrant colorectal surgery. A second limitation concerns 
the robotic system. Collisions between robotic arms are inevi-
table owing to the huge size of robotic arms compared to the 
small abdominal belly, especially for low body-mass-index pa-
tients. Loss of haptic sensation at the instrument tip is also prob-
lematic. Robotic surgery cannot even offer the indirect or direct 
touch sensation that laparoscopic or open surgery does. Third, 
relatively few robotic instruments are available to colorectal 
surgeon. There are no suction, irrigation, or stapling devices 
for robotic surgery. In the current system, these functions can 
only be performed by the assisting doctor. However, progress 
in mechanical fields is continuing. Therefore, we expect these 
technical limitations of the robotic system to be overcome with 
further advances in technology in the near future.
CONCLUSION
Anyone who has had the opportunity to work with a robotic 
surgical system can appreciate its advantages in terms of visu-
alization, precision, and ergonomics, compared with the con-
ventional laparoscopic system or open surgery. However, many 
socioeconomic issues remain to be solved in the future. In ad-
dition, we need more concrete evidence regarding the merits 
for both patients and surgeons, as well as the merits over con-
ventional laparoscopic techniques. Therefore, we need large-
scale prospective randomized clinical trials to prove the poten-
tial benefits of robot TME for the treatment of rectal cancer. 
Fortunately, robotic versus laparoscopic resection for rectal 
cancer (ROLARR) clinical trials have now begun.
The most important point is that a complete understanding 
of fundamental surgical techniques for the treatment of rectal 
cancer should be kept in mind because the extent of surgery 
and the quality of surgery must be the same regardless of the 
method of surgery, either open, laparoscopy, or robotic. In ad-
dition, a multimodality team approach should be kept in mind 
for improving oncologic outcomes and quality of life. 
With technical advancement, evolutionary change of surgical 
treatment modality should be achieved gradually. We must care-
fully evaluate cost-effectiveness and validate the safety of new 
modalities. With continued technological improvements, ro-
botic surgery should become cheaper, more efficient, and more 
automated. In the near future, robotic surgery may prove ad-
vantageous and may revolutionize minimally invasive surgery 
and radically change the paradigm of laparoscopy. Using these 
achievements of technical progress, we expect lowering the con-
version rate, autonomic nerve preservation and completeness 
of TME to be more easily achieved by using a robotic system 
for the treatment of rectal cancer.
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